Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
13.02
-0.40 (-2.98%)
Feb 21, 2025, 4:00 PM EST - Market closed
Arcutis Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,524 | 305 | 901 | 1,043 | 1,225 | - | |
| Market Cap Growth | 232.05% | -66.18% | -13.58% | -14.88% | - | - | |
| Enterprise Value | 1,402 | 283 | 626 | 681 | 1,039 | - | |
| Last Close Price | 13.02 | 3.23 | 14.80 | 20.74 | 28.13 | - | |
| PS Ratio | 10.60 | 5.11 | 244.56 | - | - | - | |
| PB Ratio | 9.72 | 3.44 | 4.30 | 3.50 | 4.53 | - | |
| P/TBV Ratio | 7.40 | 3.71 | 4.45 | 3.50 | 4.53 | - | |
| EV/Sales Ratio | 10.10 | 4.74 | 169.88 | - | - | - | |
| Debt / Equity Ratio | 1.33 | 2.32 | 0.97 | 0.26 | 0.02 | 0.00 | |
| Asset Turnover | 0.38 | 0.15 | 0.01 | - | - | - | |
| Inventory Turnover | 1.04 | 0.48 | - | - | - | - | |
| Quick Ratio | 2.27 | 6.38 | 11.06 | 11.61 | 12.61 | 19.36 | |
| Current Ratio | 2.46 | 7.08 | 11.57 | 12.09 | 12.96 | 20.33 | |
| Return on Equity (ROE) | -192.31% | -175.79% | -122.80% | -72.62% | -72.93% | -56.10% | |
| Return on Assets (ROA) | -31.14% | -38.12% | -43.97% | -36.54% | -42.15% | -34.10% | |
| Return on Capital (ROIC) | -36.88% | -42.65% | -47.89% | -39.67% | -45.26% | -35.94% | |
| Earnings Yield | -12.83% | -85.99% | -34.55% | -19.78% | -11.07% | - | |
| FCF Yield | -11.01% | -81.18% | -28.63% | -16.84% | -9.25% | - | |
| Buyback Yield / Dilution | -84.05% | -25.94% | -11.39% | -38.51% | -1835.11% | -48.68% | |
| Total Shareholder Return | -84.05% | -25.94% | -11.39% | -38.51% | -1835.11% | -48.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.